Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
---|
03/27/2014 | WO2014044691A1 Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors |
03/27/2014 | WO2014019908A3 Substituted pyrroles active as kinases inhibitors |
03/27/2014 | US20140088121 HSP90 Inhibitors |
03/27/2014 | US20140088099 Chemical compounds, compositions and methods for kinase modulation |
03/27/2014 | US20140088088 Anti-cancer activity of novel bicyclic heterocycles |
03/26/2014 | CN103664944A Preparation method of acyclovir |
03/26/2014 | CN103664943A Preparation method of purine derivative as well as intermediate and application of purine derivative |
03/25/2014 | US8680108 Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
03/25/2014 | CA2563699C Kinase modulators and method of use |
03/20/2014 | WO2010129816A3 Heterocyclic compounds and uses thereof |
03/20/2014 | US20140080827 Novel kinase modulators |
03/20/2014 | US20140080769 Substrate reduction therapy |
03/19/2014 | EP2707368A1 Polymorph of linagliptin benzoate |
03/19/2014 | CN103649089A Pyrrolotriazinone derivatives as PI3K inhibitors |
03/19/2014 | CN103649085A Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
03/19/2014 | CN103649074A Substituted azaheterocycles for the treatment of cancer |
03/19/2014 | CN103641833A Compounds and compositions as protein kinase inhibitors |
03/19/2014 | CN103641816A Compounds and compositions as protein kinase inhibitors |
03/19/2014 | CN103638778A Sulfur dioxide gas collection medium |
03/19/2014 | CN102746304B Purinamine compound and preparation method thereof |
03/13/2014 | WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor |
03/13/2014 | US20140073656 SERMS for the Treatment of Estrogen Receptor-Mediated Disorders |
03/13/2014 | US20140073632 Treating protein folding disorders with small molecule cftr correctors |
03/13/2014 | US20140073624 Biaryl Heterocyclic Compounds and Methods of Making and Using the Same |
03/13/2014 | US20140073606 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections |
03/12/2014 | EP2705029A1 Novel compounds as modulators of protein kinases |
03/12/2014 | CN102775405B High-solubility doxofylline compound |
03/12/2014 | CN101925602B Crystalline form of abacavir that is essentially free of solvent |
03/06/2014 | WO2014035064A1 The novel tenofovir disoproxil salt and the preparation method thereof |
03/06/2014 | US20140066620 Pyrimidine substituted purine derivatives |
03/06/2014 | US20140066434 Methods and Compositions for Treating Parkinson's Disease |
03/06/2014 | US20140066395 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections |
03/06/2014 | US20140066386 Therapies for hematologic malignancies |
03/05/2014 | EP2702061A1 Pyrrolotriazinone derivatives as pi3k inhibitors |
03/04/2014 | US8664232 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
02/27/2014 | WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives |
02/27/2014 | US20140058103 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture |
02/27/2014 | US20140057901 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
02/27/2014 | US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
02/26/2014 | EP2700638A1 Purine analogs |
02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
02/25/2014 | US8658792 Carbanucleoside synthesis and novel intermediate compounds useful therein |
02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
02/20/2014 | US20140051654 Substituted Purine and 7-Deazapurine Compounds |
02/19/2014 | CN103596955A HSP90 inhibitors |
02/19/2014 | CN103596954A Polymorph of Linagliptin benzoate |
02/18/2014 | US8653090 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents |
02/18/2014 | US8653089 Heterocyclic compounds and methods of use |
02/18/2014 | US8653088 Compositions useful as inhibitors of protein kinases |
02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta |
02/18/2014 | CA2744857C Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug |
02/13/2014 | WO2014026198A1 Inhibitors of protein methyltransferase dot1l and methods of use thereof |
02/13/2014 | WO2014026073A1 Compositions with increased stability for inhibiting transient receptor potential ion channel trpa1 |
02/13/2014 | WO2014023083A1 PI3Kδ INHIBITOR |
02/13/2014 | US20140046060 Method of utilizing recycled deuterium oxide in the synthesis of deuterated compounds |
02/13/2014 | US20140045867 HSP90 Inhibitors |
02/13/2014 | US20140045866 Purine-based triazoles |
02/13/2014 | US20140045837 9-Substituted 8-Oxoadenine Compound |
02/13/2014 | US20140045825 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture |
02/13/2014 | US20140045824 Method for producing complex crystal and method for screening complex crystal |
02/12/2014 | EP2694506A1 Hsp90 inhibitors |
02/12/2014 | EP2694505A1 Hsp90 inhibitors |
02/12/2014 | EP2694482A1 Wnt pathway antagonists |
02/12/2014 | CN103582642A HSP90 inhibitors |
02/12/2014 | CN103570717A Compounds with capability of combining protein gp96 and application of compounds to resistance to breast cancer |
02/12/2014 | CN103570716A Unhydrous crystal form of ganciclovir sodium and preparation method thereof |
02/06/2014 | WO2014019908A2 Substituted pyrroles active as kinases inhibitors |
02/05/2014 | CN103562207A Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir |
02/05/2014 | CN103554110A Preparation method for synthesizing doxofylline |
02/05/2014 | CN103554109A Multiple crystal forms of istradefylline |
02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
02/04/2014 | US8642607 4H-chromen-4-one compounds as modulators of protein kinases |
02/04/2014 | CA2618633C Adenine derivatives |
01/30/2014 | WO2014015830A1 Novel heteroaryl and heterocycle compounds, composition and methods thereof |
01/30/2014 | WO2014015523A1 Novel heteroaryl and heterocycle compounds, compositions and methods |
01/30/2014 | WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
01/30/2014 | US20140031539 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
01/30/2014 | US20140031375 A1 adenosine receptor antagonists |
01/30/2014 | US20140031355 Heterocyclic compounds and their uses |
01/29/2014 | CN101835779B Purine derivatives useful as PI3 kinase inhibitors |
01/28/2014 | US8637669 Production method for adefovir dipivoxil |
01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
01/28/2014 | US8637530 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals |
01/28/2014 | US8637527 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
01/23/2014 | US20140024664 Novel adenine derivatives |
01/23/2014 | US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97 |
01/22/2014 | CN103524585A Method of preparing zeitin compound by applying ionic liquid |
01/22/2014 | CN103524505A Crystal type ganciclovir sodium hydrate and preparing method thereof |
01/22/2014 | CN103524504A Guanine derivative as well as preparation method and application thereof |
01/22/2014 | CN103524503A Doxofylline hemihydrate |
01/22/2014 | CN102630226B Entecavir synthesis method and intermediate compound thereof |
01/22/2014 | CN101503409B 8-(3-amino-piperidin-1-yl)-xanthines, the production thereof and the use of the same as medicaments |
01/22/2014 | CN101048409B Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
01/21/2014 | CA2522637C Modified irna agents |
01/15/2014 | CN103509023A Xanthine derivative |
01/15/2014 | CN103509022A Xanthine derivative |
01/15/2014 | CN102203067B Hedgehog pathway modulators |
01/14/2014 | US8629285 Imidazole compounds that modulate HSP90 activity |
01/14/2014 | CA2746740C Purine compounds |